DMAC DiaMedica Therapeutics Inc.

NASDAQ
$8.38

DiaMedica Therapeutics Inc. (DMAC) Earnings News

Earnings press releases, previews and reviews for DiaMedica Therapeutics Inc. (DMAC), newest first. Our most recent is review: DiaMedica's Narrow Miss Matters Less Than Its Shrinking Runway and Slipping Timelines Ahead of Two Binary Catalysts.